Literature DB >> 20123848

Progress and applications of mouse models for human lung cancer.

S de Seranno1, R Meuwissen.   

Abstract

The continued progress of modelling lung cancer in mice has led not only to new means of understanding the molecular pathways governing human lung cancer, but it has also created a vast reservoir of alternative tools to test treatments against this malignancy. More sophisticated somatic mouse models for nonsmall cell lung cancer, small cell lung cancer and pulmonary squamous cell carcinoma have been generated that closely mimic human lung cancer. These models enable us to identify the cells of origin and the role of stem cells in the maintenance of the various types of lung cancer. Moreover, results of lung cancer intervention studies are now starting to reveal the full potential of these somatic mouse models as powerful pre-clinical models.

Entities:  

Mesh:

Year:  2010        PMID: 20123848     DOI: 10.1183/09031936.00124709

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  13 in total

1.  Differential transcriptomic analysis of spontaneous lung tumors in B6C3F1 mice: comparison to human non-small cell lung cancer.

Authors:  Arun R Pandiri; Robert C Sills; Vincent Ziglioli; Thai-Vu T Ton; Hue-Hua L Hong; Stephanie A Lahousse; Kevin E Gerrish; Scott S Auerbach; Keith R Shockley; Pierre R Bushel; Shyamal D Peddada; Mark J Hoenerhoff
Journal:  Toxicol Pathol       Date:  2012-06-11       Impact factor: 1.902

Review 2.  Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities.

Authors:  Mathew Suji Eapen; Philip M Hansbro; Anna-Karin Larsson-Callerfelt; Mohit K Jolly; Stephen Myers; Pawan Sharma; Bernadette Jones; Md Atiqur Rahman; James Markos; Collin Chia; Josie Larby; Greg Haug; Ashutosh Hardikar; Heinrich C Weber; George Mabeza; Vinicius Cavalheri; Yet H Khor; Christine F McDonald; Sukhwinder Singh Sohal
Journal:  Drugs       Date:  2018-11       Impact factor: 9.546

Review 3.  Molecular determinants of lung cancer metastasis to the central nervous system.

Authors:  Timothy G Whitsett; Landon J Inge; Harshil D Dhruv; Philip Y Cheung; Glen J Weiss; Ross M Bremner; Jeffrey A Winkles; Nhan L Tran
Journal:  Transl Lung Cancer Res       Date:  2013-08

4.  Animal models in carotenoids research and lung cancer prevention.

Authors:  Jina Kim; Yuri Kim
Journal:  Transl Oncol       Date:  2011-10-01       Impact factor: 4.243

Review 5.  Cyclin E transgenic mice: discovery tools for lung cancer biology, therapy, and prevention.

Authors:  Sarah J Freemantle; Ethan Dmitrovsky
Journal:  Cancer Prev Res (Phila)       Date:  2010-12

Review 6.  Rebuilding cancer metastasis in the mouse.

Authors:  Meera Saxena; Gerhard Christofori
Journal:  Mol Oncol       Date:  2013-02-20       Impact factor: 6.603

Review 7.  C4.4A as a biomarker in pulmonary adenocarcinoma and squamous cell carcinoma.

Authors:  Benedikte Jacobsen; Mette Camilla Kriegbaum; Eric Santoni-Rugiu; Michael Ploug
Journal:  World J Clin Oncol       Date:  2014-10-10

Review 8.  Preclinical Murine Models for Lung Cancer: Clinical Trial Applications.

Authors:  Amelia Kellar; Cay Egan; Don Morris
Journal:  Biomed Res Int       Date:  2015-05-03       Impact factor: 3.411

9.  Alveolar type II cells possess the capability of initiating lung tumor development.

Authors:  Chuwen Lin; Hai Song; Cecilia Huang; Erica Yao; Rhodora Gacayan; Shan-Mei Xu; Pao-Tien Chuang
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

10. 

Authors:  Paulina Rampetsreiter; Emilio Casanova; Robert Eferl
Journal:  Drug Discov Today Dis Models       Date:  2011-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.